rs375008004

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_012282.4(KCNE5):​c.305A>C​(p.Glu102Ala) variant causes a missense change. The variant allele was found at a frequency of 0.0000158 in 1,203,630 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 5 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E102K) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000018 ( 0 hom., 1 hem., cov: 25)
Exomes 𝑓: 0.000016 ( 0 hom. 4 hem. )

Consequence

KCNE5
NM_012282.4 missense

Scores

1
5
10

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 4.58

Publications

0 publications found
Variant links:
Genes affected
KCNE5 (HGNC:6241): (potassium voltage-gated channel subfamily E regulatory subunit 5) This gene encodes a member of a family of single pass transmembrane domain proteins that function as ancillary subunits to voltage-gated potassium channels. Members of this family affect diverse processes in potassium channel regulation, including ion selectivity, voltage dependence, and anterograde recycling from the plasma membrane. Variants of this gene are associated with idiopathic ventricular fibrillation and Brugada syndrome. [provided by RefSeq, Nov 2016]
ACSL4 (HGNC:3571): (acyl-CoA synthetase long chain family member 4) The protein encoded by this gene is an isozyme of the long-chain fatty-acid-coenzyme A ligase family. Although differing in substrate specificity, subcellular localization, and tissue distribution, all isozymes of this family convert free long-chain fatty acids into fatty acyl-CoA esters, and thereby play a key role in lipid biosynthesis and fatty acid degradation. This isozyme preferentially utilizes arachidonate as substrate. The absence of this enzyme may contribute to the cognitive disability or Alport syndrome. Alternative splicing of this gene generates multiple transcript variants. [provided by RefSeq, Jan 2016]
ACSL4 Gene-Disease associations (from GenCC):
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: DEFINITIVE, MODERATE, SUPPORTIVE Submitted by: ClinGen, Illumina, Orphanet
  • intellectual disability, X-linked 63
    Inheritance: XL Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.23668426).
BS2
High AC in GnomAdExome4 at 17 Unknown,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNE5NM_012282.4 linkc.305A>C p.Glu102Ala missense_variant Exon 1 of 1 ENST00000372101.3 NP_036414.1 Q9UJ90

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNE5ENST00000372101.3 linkc.305A>C p.Glu102Ala missense_variant Exon 1 of 1 6 NM_012282.4 ENSP00000361173.2 Q9UJ90
ACSL4ENST00000439581.1 linkn.387-395A>C intron_variant Intron 2 of 2 3

Frequencies

GnomAD3 genomes
AF:
0.0000177
AC:
2
AN:
112887
Hom.:
0
Cov.:
25
show subpopulations
Gnomad AFR
AF:
0.0000321
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000188
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000156
AC:
17
AN:
1090743
Hom.:
0
Cov.:
31
AF XY:
0.0000112
AC XY:
4
AN XY:
358205
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26242
American (AMR)
AF:
0.00
AC:
0
AN:
34346
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19197
East Asian (EAS)
AF:
0.00
AC:
0
AN:
29835
South Asian (SAS)
AF:
0.00
AC:
0
AN:
53218
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
39359
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4117
European-Non Finnish (NFE)
AF:
0.0000203
AC:
17
AN:
838647
Other (OTH)
AF:
0.00
AC:
0
AN:
45782
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000177
AC:
2
AN:
112887
Hom.:
0
Cov.:
25
AF XY:
0.0000285
AC XY:
1
AN XY:
35149
show subpopulations
African (AFR)
AF:
0.0000321
AC:
1
AN:
31147
American (AMR)
AF:
0.00
AC:
0
AN:
10837
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2649
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3511
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2821
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6300
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
233
European-Non Finnish (NFE)
AF:
0.0000188
AC:
1
AN:
53182
Other (OTH)
AF:
0.00
AC:
0
AN:
1530
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000169
Hom.:
1
Bravo
AF:
0.0000113
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000150
AC:
1
ExAC
AF:
0.00000831
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Brugada syndrome Uncertain:1
Oct 17, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces glutamic acid, which is acidic and polar, with alanine, which is neutral and non-polar, at codon 102 of the KCNE5 protein (p.Glu102Ala). This variant is present in population databases (rs375008004, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with KCNE5-related conditions. ClinVar contains an entry for this variant (Variation ID: 240861). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C65"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.059
T
BayesDel_noAF
Benign
-0.32
CADD
Benign
17
DANN
Uncertain
0.99
DEOGEN2
Benign
0.30
T
FATHMM_MKL
Uncertain
0.91
D
LIST_S2
Benign
0.49
T
M_CAP
Pathogenic
0.33
D
MetaRNN
Benign
0.24
T
MetaSVM
Benign
-0.30
T
PhyloP100
4.6
PrimateAI
Uncertain
0.59
T
PROVEAN
Uncertain
-2.4
N
REVEL
Benign
0.26
Sift
Benign
0.030
D
Sift4G
Uncertain
0.024
D
Polyphen
0.29
B
Vest4
0.11
MVP
0.076
MPC
0.45
ClinPred
0.59
D
GERP RS
4.3
PromoterAI
-0.019
Neutral
Varity_R
0.20
gMVP
0.67
Mutation Taster
=58/42
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs375008004; hg19: chrX-108867945; API